ATE252369T1 - Konservierungssysteme fur cyclodextrine enthaltende arzneimittel - Google Patents
Konservierungssysteme fur cyclodextrine enthaltende arzneimittelInfo
- Publication number
- ATE252369T1 ATE252369T1 AT97936482T AT97936482T ATE252369T1 AT E252369 T1 ATE252369 T1 AT E252369T1 AT 97936482 T AT97936482 T AT 97936482T AT 97936482 T AT97936482 T AT 97936482T AT E252369 T1 ATE252369 T1 AT E252369T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- alkyl
- alkene
- sec
- products containing
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 229940097362 cyclodextrins Drugs 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000004321 preservation Methods 0.000 title 1
- 150000001336 alkenes Chemical class 0.000 abstract 3
- -1 benzalkonium halide compounds Chemical class 0.000 abstract 2
- 239000003755 preservative agent Substances 0.000 abstract 2
- 230000002335 preservative effect Effects 0.000 abstract 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000006528 (C2-C6) alkyl group Chemical group 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000003868 ammonium compounds Chemical class 0.000 abstract 1
- 229960001716 benzalkonium Drugs 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2245396P | 1996-08-09 | 1996-08-09 | |
| PCT/US1997/014119 WO1998006381A1 (en) | 1996-08-09 | 1997-08-08 | Preservative systems for pharmaceutical compositions containing cyclodextrins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE252369T1 true ATE252369T1 (de) | 2003-11-15 |
Family
ID=21809676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97936482T ATE252369T1 (de) | 1996-08-09 | 1997-08-08 | Konservierungssysteme fur cyclodextrine enthaltende arzneimittel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5985310A (de) |
| EP (1) | EP0877600B1 (de) |
| JP (1) | JP4215277B2 (de) |
| AT (1) | ATE252369T1 (de) |
| AU (1) | AU709580B2 (de) |
| CA (1) | CA2232435C (de) |
| DE (1) | DE69725704T2 (de) |
| DK (1) | DK0877600T3 (de) |
| ES (1) | ES2207748T3 (de) |
| PT (1) | PT877600E (de) |
| WO (1) | WO1998006381A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9802864D0 (sv) * | 1998-08-27 | 1998-08-27 | Pharmacia & Upjohn Ab | Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder |
| WO2000012137A1 (en) * | 1998-09-02 | 2000-03-09 | Allergan Sales, Inc. | Preserved cyclodextrin-containing compositions |
| US6211238B1 (en) * | 1998-10-27 | 2001-04-03 | Alcon Laboratories, Inc. | Preservative system for topically administrable pharmaceutical compositions |
| DE60136926D1 (de) * | 2000-05-02 | 2009-01-22 | Theravance Inc | Zusammensetzung die eine zyklodextrin und ein glykopeptid-antibiotikum enthält |
| US7034013B2 (en) * | 2001-03-20 | 2006-04-25 | Cydex, Inc. | Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| EP1478404A1 (de) * | 2002-02-22 | 2004-11-24 | Pharmacia Corporation | Ophthalmische antibiotische arzneimittel formulierungen enthaltend eine cyclodextrin verbindung und cetylpyridiniumchlorid |
| PT1747023E (pt) | 2004-05-04 | 2011-04-11 | Univ Leland Stanford Junior | Métodos e composições para reduzir quantidades de genoma viral numa célula alvo |
| US6969706B1 (en) * | 2004-05-12 | 2005-11-29 | Allergan, Inc. | Preserved pharmaceutical compositions comprising cyclodextrins |
| WO2006040839A1 (ja) * | 2004-10-15 | 2006-04-20 | Advanced Medicine Research Institute | 眼疾患処置用点眼剤及びキット |
| EP2671508B1 (de) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-Informatiksystem |
| US20070238789A1 (en) * | 2006-03-31 | 2007-10-11 | Chin-Ming Chang | Prednisolone acetate compositions |
| AR066901A1 (es) * | 2007-05-18 | 2009-09-23 | Alcon Mfg Ltd | Composiciones fodfolipidicas para elcuidado de lentes de contacto y conservacion de composiciones farmaceuticas |
| WO2009114325A2 (en) | 2008-03-03 | 2009-09-17 | Tosk, Incorporated | Methotrexate adjuvants to reduce toxicity and methods for using the same |
| BRPI0912302A2 (pt) * | 2008-05-28 | 2015-10-20 | Alcon Res Ltd | emulsões autopreservados |
| TW201010727A (en) * | 2008-09-03 | 2010-03-16 | Alcon Res Ltd | Pharmaceutical composition having relatively low ionic strength |
| KR20110099044A (ko) * | 2008-12-22 | 2011-09-05 | 알콘 리서치, 리미티드 | 후안부에 유효농도의 활성제를 전달하기 위한 국소 안용액 조성물 |
| US8569254B2 (en) | 2010-12-10 | 2013-10-29 | National Yang Ming University | Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same |
| TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物 |
| EP2630952A1 (de) * | 2012-02-23 | 2013-08-28 | Novagali Pharma S.A. | Selbstkonservierende Öldispersionen enthaltend Borsäure |
| PT3307296T (pt) | 2015-06-15 | 2022-01-07 | Univ Leland Stanford Junior | Timp2 para uso no tratamento de condições associadas ao envelhecimento |
| PT3548091T (pt) | 2016-11-29 | 2022-01-21 | Oculis SA | Preparação de complexos sólidos de ciclodextrina para administração oftálmica de ingrediente farmacêutico ativo |
| US11446303B2 (en) | 2019-06-21 | 2022-09-20 | Tosk, Inc. | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions |
| WO2021001366A1 (en) | 2019-07-01 | 2021-01-07 | Oculis SA | Method for stabilizing the ph of an aqueous composition comprising a drug |
| CN118647364A (zh) | 2022-02-02 | 2024-09-13 | 奥库里斯经营管理有限责任公司 | 多剂量眼用组合物 |
| CA3251059A1 (en) | 2022-05-02 | 2023-11-09 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions, systems and methods for modulating a target gene |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209449A (en) * | 1978-11-30 | 1980-06-24 | Mona Industries | Phosphate quaternary compounds |
| US4407791A (en) * | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
| JPS59152320A (ja) * | 1983-02-17 | 1984-08-31 | Takeda Chem Ind Ltd | 水性製剤 |
| DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
| JPS60149530A (ja) * | 1984-01-13 | 1985-08-07 | Takeda Chem Ind Ltd | 水性製剤 |
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| US4870060A (en) * | 1985-03-15 | 1989-09-26 | Janssen Pharmaceutica | Derivatives of γ-cylodextrin |
| US5322667A (en) * | 1987-03-31 | 1994-06-21 | Sherman Pharmaceuticals, Inc. | Preservative system for ophthalmic and contact lens solutions and method for cleaning disinfecting and storing contact lenses |
| JPS6416718A (en) * | 1987-06-22 | 1989-01-20 | Three S Tech Bv | Skin adhesive patch |
| US5298182A (en) * | 1989-01-31 | 1994-03-29 | Ciba-Geigy Corporation | Rapid ophthalmic glycol/lower alkanol cleaning and disinfecting solution and method |
| US5089053A (en) * | 1989-11-09 | 1992-02-18 | Polymer Technology Corporation | Contact lens cleaning material and method |
| US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US5286719A (en) * | 1991-10-28 | 1994-02-15 | Mona Industries, Inc. | Phospholipid virucidal compositions |
| JPH0616547A (ja) * | 1992-07-01 | 1994-01-25 | Wakamoto Pharmaceut Co Ltd | 消炎点眼剤 |
| US5683709A (en) * | 1994-05-05 | 1997-11-04 | Ciba Vision Corporation | Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions |
| AU684950B2 (en) * | 1994-05-06 | 1998-01-08 | Alcon Laboratories, Inc. | Use of vitamin E tocopheryl derivatives in ophthalmic compositions |
| US5603929A (en) * | 1994-11-16 | 1997-02-18 | Alcon Laboratories, Inc. | Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds |
| JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
| JPH08175985A (ja) * | 1994-12-26 | 1996-07-09 | Lion Corp | 点眼剤 |
| ATE215821T1 (de) * | 1995-01-20 | 2002-04-15 | Wakamoto Pharma Co Ltd | Entzündungshemmende augentropfen |
| TW434023B (en) * | 1995-09-18 | 2001-05-16 | Novartis Ag | Preserved ophthalmic composition |
-
1997
- 1997-08-08 WO PCT/US1997/014119 patent/WO1998006381A1/en not_active Ceased
- 1997-08-08 EP EP97936482A patent/EP0877600B1/de not_active Expired - Lifetime
- 1997-08-08 AT AT97936482T patent/ATE252369T1/de active
- 1997-08-08 AU AU39140/97A patent/AU709580B2/en not_active Expired
- 1997-08-08 PT PT97936482T patent/PT877600E/pt unknown
- 1997-08-08 CA CA002232435A patent/CA2232435C/en not_active Expired - Lifetime
- 1997-08-08 ES ES97936482T patent/ES2207748T3/es not_active Expired - Lifetime
- 1997-08-08 DK DK97936482T patent/DK0877600T3/da active
- 1997-08-08 US US09/029,943 patent/US5985310A/en not_active Expired - Lifetime
- 1997-08-08 DE DE69725704T patent/DE69725704T2/de not_active Expired - Lifetime
- 1997-08-08 JP JP50995498A patent/JP4215277B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK0877600T3 (da) | 2004-02-02 |
| WO1998006381A1 (en) | 1998-02-19 |
| US5985310A (en) | 1999-11-16 |
| AU709580B2 (en) | 1999-09-02 |
| DE69725704D1 (de) | 2003-11-27 |
| JPH11513045A (ja) | 1999-11-09 |
| DE69725704T2 (de) | 2004-05-13 |
| CA2232435A1 (en) | 1998-02-19 |
| PT877600E (pt) | 2004-02-27 |
| ES2207748T3 (es) | 2004-06-01 |
| EP0877600A1 (de) | 1998-11-18 |
| JP4215277B2 (ja) | 2009-01-28 |
| EP0877600B1 (de) | 2003-10-22 |
| AU3914097A (en) | 1998-03-06 |
| CA2232435C (en) | 2006-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69725704D1 (de) | Konservierungssysteme fur cyclodextrine enthaltende arzneimittel | |
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
| NO307326B1 (no) | Lipofile, oligosakkaride antibiotikasaltpreparater | |
| ATE61050T1 (de) | Pyridazinamine wirksam gegen viren. | |
| ES2061848T3 (es) | Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
| KR950016732A (ko) | 피부 및 질의 위축 억제방법 | |
| ATE131730T1 (de) | Nukleosidanalogen enthaltende antiviren- zubereitungen | |
| BR9701248A8 (pt) | compostos para a terapia de tumores e distérbios inflamatàrios, produto farmacÊutico e formulaÇço farmacÊutica dos mesmos | |
| DK0989851T3 (da) | Selvemulgerende formulering indeholdende sure lipofile forbindelser | |
| FI913433A0 (fi) | Foerfarande foer foerhindrande eller begraensande av skada vid aoterstroemning av blod genom ett organ eller en vaevnad. | |
| CA2390558A1 (en) | Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same | |
| IT1301968B1 (it) | Derivati di eritromicina ad attivita' antibiotica | |
| KR890005088A (ko) | 4- 아미노피리딘 유도체 및 그의 산 부가염 | |
| GEP20032970B (en) | Pharmaceutical Compositions of Tizoxanide and Nitazoxanide | |
| IT1247918B (it) | Composizioni disinfettanti polivalenti | |
| ATE119910T1 (de) | Amphotericin b derivate. | |
| KR920014818A (ko) | 항균제 | |
| RU94040865A (ru) | Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью | |
| SE8303719L (sv) | Eburnan-oximderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar | |
| DE59205998D1 (de) | Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung | |
| ES2179667T3 (es) | Nuevas formulaciones inyectables que contienen ramoplanina. | |
| ES2124844T3 (es) | Palau'amina: un compuesto farmacologicamente activo aislado a partir de una esponja. | |
| KR960037045A (ko) | B형 바이러스(hbv)성 간염의 예방 및 치료용 약학적 제제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0877600 Country of ref document: EP |